THE FIRST REAL BREAKTHROUGH IN
PROSTATE HEALTH IN THE LAST DECADE
BPH affects more than 50% of men over the age of 60
MECHANISM OF ACTION
Patent pending ProstaTone™ is different to any other formula currently available for prostate health. ProstaTone jointly supports the prostate and the bladder to maintain healthy prostate and bladder function.
The focus of current options for prostate health is only the prostate itself. Yet research shows that prostate enlargement directly affects the bladder and urethra as well, contributing to long term weakness in this area.
ProstaTone combines therapeutic doses of crateva and horsetail with saw palmetto, lycopene, zinc and selenium. Saw palmetto (Serenoa serrulata) is known to act as a 5 alpha reductase inhibitor and is antiestrogenic, and helps improve symptoms of medically diagnosed Benign Prostate Hypertrophy (BPH).
Clinical studies conducted over the last fifteen years suggest saw palmetto extract can produce major improvements in prostate-related urinary function. Both horsetail and crateva are documented in traditional texts for use with BPH.
Various antioxidants have been well documented as important for prostate health and in the relief of BPH symptoms. Selenium and lycopene (derived from tomato, Lycopersicon esulentum) prevent disease of the prostate and are beneficial in cases of BPH.
Zinc acts as a 5 alpha reductase inhibitor and is considered to play an important role in the etiology of BPH..
Clinical research indicates that ProstaTone is effective in reducing the symptoms of overactive bladder and BPH.
A 33 participant study was undertaken to investigate and report the efficacy of ProstaTone in treating the symptoms of medically diagnosed Benign Prostate Hypertrophy (BPH) in men.
There was a significant gradual reduction in day time urinary frequency (35%, p<0.005) over the 3 months. Night time urinary frequency significantly reduced in the first month and this trend continued to Month 3 (62%, p<0.005).
There was a significant reduction in the average prostate symptoms score over the 3 months, with the greatest improvement being seen in questions relating to nocturia and urinary fl ow (particularly the symptom “difficulty emptying bladder”).
There was also a significant improvement measured for quality of life indicators.
At completion of the study, 29 of the 33 subjects (88%) wanted to continue with treatment.
• Raw horsetail contains a thiaminase-like enzyme. This enzyme breaks down thiamine (vitamin B1) in the body. The horsetail used in ProstaTone is extracted using a method that destroys this thiaminase-like effect. Therefore, ProstaTone does not cause vitamin B1depletion that may be associated with some forms of horsetail.
• Serenoa serrulata (saw palmetto) is standardized to contain 85% fatty acids.
• Lycopersicon esculentum (tomato) is standardised for lycopene content.
• Soft gel encapsulation of ProstaTone ensures bioavailability and stability of formula..
• U.S. and PCT patents pending
• Softgel encapsulation
• Available as bulk or packaged
• Packaged in units of 60
• Packaged in HDPE tampertell bottle
• Co-branding available
|Serving size: 2 Softgels|
|Servings per container: 30|
|Amount per serving||% Daily Value|
|Zinc (from zinc citrate)||15 mg||100%|
|Selenium (from selenomethionine)||24 mcg||34%|
|Proprietary blend||1,045 mg||*|
|Three-leaf caper (Opteva) (Crateva nurvala) (stem bark) |
Horsetail (Equisetum arvense) (herb)
Saw Palmetto (Serenoa repens) (fruit)
Standardized to contain 272 to 288mg fatty acids and sterols
|Tomato (Lycopersicon esculentum) (fruit) 350:1 |
Contains phytonutrients, lycopene, phytoene,
phytofl uene, betacarotene, phytosterols and
|*Daily value not established|
|Gelatin, soya oil, glycerol, maltodextrin, purified water lecithin, d-alpha-tocopherol|
Recommended Adult Dosage
Take two softgels daily with meals, until symptom relief is apparent. Results are expected within 2-4 weeks. Allow 2-3 months for best results. Clinical studies have shown that a small number (<2%) of men experience gastrointestinal symptoms such as looser or firmer stools..
• Badmaev, V., Majeed, M., Passwater, R. Selenium: A quest for better understanding. Alternative Therapies 1996; 2(4):59-67.
• Compare F, Mahmoud A .Preventing diseases of the prostate in the elderly using hormones and nutriceuticals. Aging Male. 2004 Jun;7(2):155-69
• Cristoni A, Di Pierro F, Bombardelli E. Botanical derivatives for the prostate. Fitoterapia. 2000 Aug;71 Suppl1:S21-8.
• Lagiou P, Wuu J, Trichopoulou A, Hsieh CC, Adami HO,Trichopoulou D. Diet and benign prostatic hyperplasia: a study in Greece. Urology. 1999 Aug;54(2):284-90.
• Nadkarni KM. Indian Materia Medica. Bombay Popular Prakashan.
• Pruess HG, Marcusen C, Regan J, KlimbergI W, Welebir TA, Jones WA. Randomized trial of a combination of natural products (cernitin, saw palmetto, B-sitosterol, vitamin E) on symptoms of benign prostatic hyperplasia (BPH).Int Urol Nephrol. 2001;33 (2):217-25.
• The Complete German Commission E Monographs. 1998, Blumenthal, M., ed., Austin, TX: American Botanical Council.
• The British Herbal Pharmacopeia. Publ: Brisbane Herbal Medicine Association, 1983.
• Wallace, A.M., Grant, J.K. Effect of zinc on androgen metabolism in the human hyperplastic prostate.
Biochemical Society Transactions 1975; 3(3):540-42
• Zachara BA, Szewczyk-GolecK, Tyloch J, Wolski Z, Szylberg T, Stepien S, Kwiatkowski S, Blach-Boguslawaska E, Wasowicz W. Blood and tissue selenium concentrations and glutathione peroxidase activities in patients with prostate cancer and benign prostate hyperplasia. Neoplasma. 2005;52(3):248-54.
The statements in this information sheet have not been evaluated by the food and drug administration.
This product is not intended to diagnose, treat, cure, or prevent any disease.
FURTHER INFORMATION AVAILABLE
• Certificate of analysis
• Stability data
• Allergen statement
• BSE free statement
• Published and unpublished research
• Product support information.